Rossi J, Zedde M, Napoli M, Pascarella R, Pisanello A, Biagini G
Life (Basel). 2025; 14(12.
PMID: 39768232
PMC: 11677825.
DOI: 10.3390/life14121523.
Liu D, Zheng M, Lu C, Miao M, Zhan Y, Ma F
J Lipids. 2024; 2024:5513473.
PMID: 39554996
PMC: 11567725.
DOI: 10.1155/2024/5513473.
Zhang D, Chen H, Wang J, Ji J, Imam M, Zhang Z
Front Cell Dev Biol. 2024; 12:1338448.
PMID: 38476263
PMC: 10928007.
DOI: 10.3389/fcell.2024.1338448.
Hall K, Filardo E
Cells. 2023; 12(20).
PMID: 37887304
PMC: 10605794.
DOI: 10.3390/cells12202460.
Luo W, Yan Y, Cao Y, Zhang Y, Zhang Z
Front Mol Biosci. 2023; 10:1097018.
PMID: 37021109
PMC: 10069632.
DOI: 10.3389/fmolb.2023.1097018.
Dissecting the molecular mechanism of cepharanthine against COVID-19, based on a network pharmacology strategy combined with RNA-sequencing analysis, molecular docking, and molecular dynamics simulation.
Liu J, Sun T, Liu S, Liu J, Fang S, Tan S
Comput Biol Med. 2022; 151(Pt A):106298.
PMID: 36403355
PMC: 9671524.
DOI: 10.1016/j.compbiomed.2022.106298.
Shikonin Mediates Apoptosis through G Protein-Coupled Estrogen Receptor of Ovarian Cancer Cells.
Liu X, Yang Y, Tang X, Guo L, Tang X, Zhu T
Evid Based Complement Alternat Med. 2022; 2022:6517732.
PMID: 36248433
PMC: 9556250.
DOI: 10.1155/2022/6517732.
High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes.
Xu T, Ma D, Chen S, Tang R, Yang J, Meng C
NPJ Breast Cancer. 2022; 8(1):100.
PMID: 36042244
PMC: 9427744.
DOI: 10.1038/s41523-022-00472-4.
Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions.
Farkas S, Szabo A, Hegyi A, Torok B, Fazekas C, Ernszt D
Biomedicines. 2022; 10(4).
PMID: 35453610
PMC: 9029610.
DOI: 10.3390/biomedicines10040861.
Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism.
Felix F, Vago J, Fernandes D, Martins D, Moreira I, Goncalves W
Front Pharmacol. 2021; 12:662308.
PMID: 33995086
PMC: 8114065.
DOI: 10.3389/fphar.2021.662308.
Role of G Protein-Coupled Estrogen Receptor in Digestive System Carcinomas: A Minireview.
Qiu Y, Xiong J, Yu T
Onco Targets Ther. 2021; 14:2611-2622.
PMID: 33888991
PMC: 8055353.
DOI: 10.2147/OTT.S291896.
Reduced Vitellogenesis and Female Fertility in Gper Knockout Zebrafish.
Wu X, Williams M, Kew K, Converse A, Thomas P, Zhu Y
Front Endocrinol (Lausanne). 2021; 12:637691.
PMID: 33790865
PMC: 8006473.
DOI: 10.3389/fendo.2021.637691.
Hormonal Regulation of Oligodendrogenesis I: Effects across the Lifespan.
Long K, Breton J, Barraza M, Perloff O, Kaufer D
Biomolecules. 2021; 11(2).
PMID: 33672939
PMC: 7918364.
DOI: 10.3390/biom11020283.
DNA methylation and expression of estrogen receptor alpha in fathead minnows exposed to 17α-ethynylestradiol.
Fetke J, Martinson J, Flick R, Huang W, Bencic D, See M
Aquat Toxicol. 2021; 233:105788.
PMID: 33662878
PMC: 8317993.
DOI: 10.1016/j.aquatox.2021.105788.
Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function.
Rouhimoghadam M, Lu A, Salem A, Filardo E
Front Endocrinol (Lausanne). 2020; 11:591217.
PMID: 33329395
PMC: 7719807.
DOI: 10.3389/fendo.2020.591217.
G Protein-Coupled Estrogen Receptor, GPER1, Offers a Novel Target for the Treatment of Digestive Diseases.
DeLeon C, Wang D, Arnatt C
Front Endocrinol (Lausanne). 2020; 11:578536.
PMID: 33281743
PMC: 7689683.
DOI: 10.3389/fendo.2020.578536.
Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation.
Molina L, Bustamante F, Ortloff A, Ramos I, Ehrenfeld P, Figueroa C
Front Endocrinol (Lausanne). 2020; 11:563165.
PMID: 33117280
PMC: 7561417.
DOI: 10.3389/fendo.2020.563165.
G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival.
Schuler-Toprak S, Skrzypczak M, Ignatov T, Ignatov A, Ortmann O, Treeck O
J Cancer Res Clin Oncol. 2020; 146(12):3175-3188.
PMID: 32813115
DOI: 10.1007/s00432-020-03333-4.
GPR30 Promotes the Phenotypic Switching of Vascular Smooth Muscle Cells via Activating the AKT and ERK Pathways.
Zha B, Qiu P, Zhang C, Li X, Chen Z
Onco Targets Ther. 2020; 13:3801-3808.
PMID: 32440148
PMC: 7212987.
DOI: 10.2147/OTT.S244128.
Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.
Yang F, Xie H, Yang L, Zhang L, Zhang F, Liu H
Autophagy. 2020; 16(6):1061-1076.
PMID: 32401166
PMC: 7469550.
DOI: 10.1080/15548627.2019.1659609.